SCA
NVO

Salient Capital Advisors’s Novo Nordisk NVO Stock Holding History

Salient Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,850
Closed -$238K – 251
2016
Q2 		$238K Sell
8,850
-78
-0.9% -$2.14K 0.01% 224
2016
Q1 		$242K Sell
8,928
-50
-0.6% -$1.34K 0.01% 222
2015
Q4 		$261K Buy
8,978
+128
+1% +$3.54K 0.01% 220
2015
Q3 		$240K Hold
8,850
– – 0.01% 217
2015
Q2 		$242K Sell
8,850
-300
-3% -$8.43K ﹤0.01% 239
2015
Q1 		$244K Buy
+9,150
New +$211K ﹤0.01% 220
2014
Q4 		– Sell
-9,150
Closed -$218K – 248
2014
Q3 		$218K Hold
9,150
– – ﹤0.01% 214
2014
Q2 		$211K Hold
9,150
– – ﹤0.01% 220
2014
Q1 		$209K Buy
+9,150
New +$195K 0.01% 209

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return